Related Experiment Video

Updated: Oct 15, 2026

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

Effect of transforming growth factor-beta1 on cytochrome P450 expression: inhibition of CYP1 mRNA and protein

G F Müller1, O Döhr, C El-Bahay

  • 1Medical Institute of Environmental Hygiene, Heinrich Heine University, Department of Toxicology, Düsseldorf, Germany.

Archives of Toxicology
|July 6, 2000
PubMed

Insights

Transforming growth factor-beta1 (TGF-beta1) inhibits cytochrome P450 (CYP) 1 isoenzyme expression in rat hepatocytes, similar to humans. This study confirms TGF-beta1

Area of Science:

  • Pharmacology and Toxicology
  • Molecular Biology
  • Hepatology

Background:

  • Primary hepatocytes are crucial for studying hepatic cytochrome P450 (CYP) isoenzyme regulation.
  • Transforming growth factor-beta1 (TGF-beta1) is known to inhibit CYP1 expression in human cells but not previously in rat cells.
  • Species-specific differences in CYP1 regulation by TGF-beta1 require further investigation.

Purpose of the Study:

  • To investigate the effect of TGF-beta1 on constitutive and TCDD-induced CYP1 isoenzyme expression in primary rat hepatocytes.
  • To determine the species-specificity of CYP1 down-regulation by TGF-beta1.
  • To compare CYP1 regulation mechanisms between rats and humans.

Main Methods:

  • Primary rat hepatocytes were treated with TGF-beta1 and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
  • CYP1 isoenzyme activities (EROD, MROD) and mRNA expression were measured using RT-PCR.
  • Protein levels of CYP isoenzymes (CYP1A2, CYP2B1/2, CYP3A1) were assessed via Western blot.

Main Results:

  • TGF-beta1 inhibited TCDD-induced CYP1 activities and mRNA expression.
  • TGF-beta1 down-regulated constitutive CYP1A2 protein expression and CYP1-related activities (EROD, MROD).
  • Constitutive mRNA expression of CYP1 isoenzymes and protein/mRNA levels of other CYP isoenzymes (CYP2B1/2, CYP2E1, CYP3A1) remained unaffected.

Conclusions:

  • TGF-beta1 inhibits both constitutive and TCDD-induced CYP1 expression in rat hepatocytes.
  • The down-regulation of CYP1 expression by TGF-beta1 is specific to CYP1 isoenzymes.
  • These findings indicate similar regulation of CYP1 expression by TGF-beta1 in both rats and humans.

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...